Provided by Tiger Trade Technology Pte. Ltd.

Brookdale Senior Living

13.94
+0.04000.29%
Pre-market: 14.190.2500+1.79%08:36 EDT
Volume:3.22M
Turnover:45.04M
Market Cap:3.31B
PE:-12.48
High:14.17
Open:13.98
Low:13.82
Close:13.90
52wk High:17.09
52wk Low:4.97
Shares:237.66M
Float Shares:233.91M
Volume Ratio:0.71
T/O Rate:1.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1170
EPS(LYR):-1.1170
ROE:-308.16%
ROA:1.07%
PB:-74.03
PE(LYR):-12.48

Loading ...

Brookdale Senior Living Is Maintained at Overweight by Barclays

Dow Jones
·
Feb 03

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Brookdale Senior Living (BKD)

TIPRANKS
·
Feb 03

Brookdale Senior Living Likely to Benefit from Rising Demand, RBC Says

MT Newswires Live
·
Feb 03

Brookdale Senior Living Is Maintained at Outperform by RBC Capital

Dow Jones
·
Jan 29

Brookdale Senior Living price target raised to $17 from $13 at RBC Capital

TIPRANKS
·
Jan 29

RBC Raises Price Target on Brookdale Senior Living to $17 From $13, Keeps Outperform Rating

MT Newswires Live
·
Jan 29

Bank of America Securities Reaffirms Their Buy Rating on Brookdale Senior Living (BKD)

TIPRANKS
·
Jan 29

Brookdale Senior Living Issues Upbeat 2025 Preliminary Outlook

TIPRANKS
·
Jan 29

Brookdale Senior Living sees 2025 revenue $3.2B, consensus $3.19B

TIPRANKS
·
Jan 29

Brookdale Senior Living sees 2026 adjusted EBITDA $502M-$516M

TIPRANKS
·
Jan 29

Brookdale Senior Living Projects 2025 Revenue of $3.2 Billion

Reuters
·
Jan 29

Brookdale Senior Living Inc Outlook FY26 Revpar Year-Over-Year Growth 8.0% to 9.0%

THOMSON REUTERS
·
Jan 29

Brookdale Senior Living Inc - Projects 2026 Adj Ebitda of $502-$516 Mln

THOMSON REUTERS
·
Jan 29

Brookdale Senior Living Inc - Expects 2025 Revenue of $3.2 Bln

THOMSON REUTERS
·
Jan 29

Brookdale Announces Preliminary Full Year 2025 Results and Introduces Full Year 2026 Annual Guidance

THOMSON REUTERS
·
Jan 29

Jefferies Sticks to Its Buy Rating for Brookdale Senior Living (BKD)

TIPRANKS
·
Jan 27

Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT), Boston Scientific (BSX) and Brookdale Senior Living (BKD)

TIPRANKS
·
Jan 26

Brookdale Senior Living Is Maintained at Overweight by Barclays

Dow Jones
·
Jan 23

Brookdale Senior Living (BKD) Gets a Buy from Jefferies

TIPRANKS
·
Jan 22

Brookdale Senior Living price target raised to $15 from $14 at Barclays

TIPRANKS
·
Jan 22